@article{be6807f3a3a14a0b90307a37115aa15c,
title = "Prescribing warfarin at discharge for heart failure patients: Findings from the Get with the Guidelines-Heart Failure Registry",
keywords = "Heart failure, Prescription rates, Warfarin",
author = "Eapen, {Zubin J.} and Grau-Sepulveda, {Maria V.} and Fonarow, {Gregg C.} and Heidenreich, {Paul A.} and Peterson, {Eric D.} and Hernandez, {Adrian F.}",
note = "Funding Information: AF Hernandez : Dr. Hernandez reports research funding from Johnson & Johnson , Amylin , and Portola ; honorarium from Corthera and Cytokinetics. All conflicts can be found at www.dcri.org . Funding Information: GC Fonarow : Dr. Fonarow reports research funding from the National Institute of Health (significant), the Agency for Healthcare Research and Quality (significant); consulting for Bayer (modest), Janssen (modest), Medtronic (modest), and Novartis (significant). ",
year = "2014",
month = mar,
day = "15",
doi = "10.1016/j.ijcard.2013.12.161",
language = "English (US)",
volume = "172",
pages = "e322--e323",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "2",
}